Prognostic and predictive value of neutrophil-to-lymphocyte ratio with adjuvant immunotherapy in stage III non-small-cell lung cancer
Alex K. Bryant, K. Nathan Sankar, Garth W. Strohbehn, Lili Zhao, David J. Elliott, Angel Qin, Sarah Yentz, Nithya Ramnath, Michael D. Green
Topics & Concepts
MedicinePredictive valueNeutrophil to lymphocyte ratioOncologyStage (stratigraphy)Lung cancerImmunotherapyInternal medicineAdjuvantLymphocyteImmunologyCancerBiologyPaleontologyInflammatory Biomarkers in Disease PrognosisCancer Immunotherapy and BiomarkersLung Cancer Diagnosis and Treatment